HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

Active, not recruitingOBSERVATIONAL
Enrollment

2,750

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Hypertrophic Cardiomyopathy
Interventions
OTHER

None - this is an observational study

None - this is an observational study

Trial Locations (44)

10016

NYU Medical Center, New York

10019

St. Luke's Roosevelt University Hospital of Columbia University, New York

10065

Weill Cornell - New York Presbyterian, New York

13125

Charite - Universitatsmedizin Berlin, Berlin

19104

Hospital of the University of Pennsylvania (Penn Heart and Vascular Center), Philadelphia

20132

San Raffaele University Hospital, Milan

22908

University of Virginia Health System, Charlottesville

27710

Duke University Medical Center, Durham

40138

Universita di Bologna, Bologna

44195

Cleveland Clinic, Cleveland

50134

Careggi University Hospital, Florence

55905

Mayo Clinic, Rochester

60611

Northwestern University Feinberg School of Medicine, Chicago

70376

Robert-Bosch-Krankenhaus GmbH, Stuttgart

77030

Methodist DeBakey Cardiology Associates, Houston

97239

Oregon Health & Science University, Portland

06520

Yale University, New Haven

21287-0409

Johns Hopkins University, Baltimore

02111

Tufts Medical Center, Boston

02115

Brigham & Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

48109-56444

University of Michigan Health System, Ann Arbor

T2N 2T9

University of Calgary, Calgary

M5G 2C4

Toronto General Research Institute (TGRI), Toronto General Hospital, Toronto

H1T 1C8

Montreal Heart Institute (Institut de Cardiologie de Montreal), Montreal

QC H3G 1B3

McGill University Health Center, Montreal

G1V 4G5

Quebec Heart Insititute, Québec

D-69120

Universitats Klinikum Heidelberg, Heidelberg

00185

Sapienza University, Rome

1081 HV

VU University Medical Center, Amsterdam

3015 CE

Erasmus MC, Rotterdam

AB25 2ZD

University of Aberdeen, School of Medicine and Dentistry, Aberdeen

G12 8TA

University of Glasgow (BHF Glasgow Cardiovascular Research Centre), Glasgow

B15 2TH

University Hospitals Birmingham (Queen Elizabeth Hospital), Birmingham

BS2 8HW

Bristol Heart Institute, Bristol

EH16 4SB

Royal Infirmary of Edinburgh, Edinburgh

LS2 9JT

University of Leeds, Leeds

LE3 9QP

Glenfield Hospital Leicester, Leicester

E2 9JX

London Chest Hospital, London

SE1 7EH

King's College London (St. Thomas' Hospital), London

SW17 0RE

St. George's Healthcare NHS Trust, London

SW3 6NP

Royal Brompton Hospital, London

OX3 9DU

Oxford University, Oxford

SO16 6YD

University of Southhamptom, Southampton

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Oxford University Hospitals NHS Trust

OTHER

lead

University of Virginia

OTHER

NCT01915615 - HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter